Latest Revenue Streaming News

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Stelar Metals has reported impressive high-grade silver assays up to 211 g/t at its Baratta Copper Project in South Australia, highlighting the project's potential as a significant copper-silver resource.

BPH Global has secured a $1 million strategic placement to accelerate growth of its Indonesian seaweed trading operations, backed by record sales and robust infrastructure. This capital injection aims to boost trading volumes and pave the way for higher-margin revenue streams.

FlexiRoam Limited reveals a strong financial turnaround with AI-powered innovations driving profitability and margin expansion in the first half of FY26. The company’s strategic partnerships and zero-integration platform position it well in the fast-growing eSIM market.

Jcurve Solutions has reported a robust Q2FY26 with a significant profit turnaround and a confident revenue outlook for FY26, driven by strong sales and recurring revenue growth.

Worley Limited has been awarded a reimbursable EPC contract for Phase 2 of the CP2 Project, reinforcing its role in a strategically vital global energy infrastructure initiative.

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.

DataWorks has secured a significant contract extension with iGaming Ontario, adding over C$12.5 million to its Centralised Self-Exclusion program services. This move strengthens its recurring revenue and solidifies its RegTech division’s profitability.

Jumbo Interactive’s preliminary 1H26 results reveal robust double-digit growth driven by SaaS and Managed Services, despite a quieter jackpot landscape. The recent acquisitions in the UK and US add momentum but introduce new accounting complexities.

CVC Limited forecasts a substantial increase in its half-year net loss, prompting the board to suspend the interim dividend amid cashflow concerns.

Adelong Gold has finalised the sale of its remaining 49% interest in Challenger Mines to Great Divide Mining, receiving 10 million GDM shares and retaining a capped royalty on future gold production.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.